Decyl-ubiquinone — The Mitochondrial Research Analogue
Decyl-ubiquinone is a synthetic analogue of Coenzyme Q10 used extensively in laboratory settings to study mitochondrial bioenergetics and electron transport chain function. While it provides valuable insights into cellular respiration and oxidative stress mechanisms, it is strictly a research tool with no established role in human longevity or clinical medicine.
Mechanism of Action
Decyl-ubiquinone is a synthetic, short-chain analogue of Coenzyme Q10 (ubiquinone) that lacks the long isoprenoid tail of the natural molecule. It functions as an electron acceptor and donor within the mitochondrial electron transport chain, specifically interacting with Complex I (NADH:ubiquinone oxidoreductase) and Complex III (cytochrome bc1 complex). In isolated mitochondria and cell cultures, it is frequently used to assay respiratory chain function, measure reactive oxygen species (ROS) production, and study the mitochondrial permeability transition pore. Its primary utility is as a biochemical probe rather than a therapeutic agent.
Human Trial Evidence
No published human longevity trials. Animal/in-vitro evidence only.
Dosing Protocol
Unestablished in humans. Used primarily as an in-vitro research tool (e.g., 50-60 μM in mitochondrial assays). Not available or recommended for human supplementation.
Safety & Contraindications
Safety profile in humans is completely unknown. As a synthetic mitochondrial uncoupler and electron transport chain modulator, inappropriate dosing could theoretically induce severe mitochondrial dysfunction, excessive oxidative stress, or cellular toxicity. Not intended for human consumption.